NCT02809768View on ClinicalTrials.gov

Study to Assess Pharmacokinetic Drug-Drug Interaction Between Avatrombopag When Co-Administered With Fluconazole, Itraconazole, or Rifampin in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

August 31, 2016

Study Completion Date

September 30, 2016

Conditions
Healthy Participants
Interventions
DRUG

Avatrombopag

DRUG

Fluconazole

DRUG

Itraconazole

DRUG

Rifampin

Trial Locations (1)

Unknown

San Antonio

All Listed Sponsors
lead

Eisai Inc.

INDUSTRY

NCT02809768 - Study to Assess Pharmacokinetic Drug-Drug Interaction Between Avatrombopag When Co-Administered With Fluconazole, Itraconazole, or Rifampin in Healthy Subjects | Biotech Hunter | Biotech Hunter